Brief：Novascan has established a real-time technology platform for cancer detection and classification. Marginscan, designed by novascan technology platform, has been able to provide accurate diagnosis of skin cancer, and has become a more rapid, economic and small amount of detection method for healthy tissues. Novascan also has the potential to integrate with other widely used instrument platforms.

Brief：Biovista uses its artificial intelligence platform to provide drug repositioning services in areas where medical needs are not met, as well as related drug and target analysis services for the pharmaceutical industry. The platform can solve the problems of effectiveness and potential toxicity of candidate drugs based on the correlation of action mechanism.

Brief：Maia biotechnology is committed to transforming cutting-edge academic achievements into original new drugs for clinical application, and developing advanced targeted therapeutic drugs based on different mechanisms for a variety of cancers. At the same time, it has an experienced drug R & D team, and cooperates with many universities and research institutions to transform a variety of world leading candidate compounds.